Psyence Biomedical

(NASDAQ) PBM

Current Price$3.33

Market Cap$997.40K

Since IPO (2021)-100%

5 YearN/A

1 Year-89%

1 Month-35%

Psyence Biomedical Financials at a Glance

Market Cap

$997.40K

Revenue (TTM)

$0.00

Net Income (TTM)

-$26.25M

EPS (TTM)

$0.00

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Price

$3.33

Volume

1,064

Open

$3.46

Price

$3.33

Volume

1,064

Open

$3.46

Previous Close

$3.33

Daily Range

$3.32 - $3.46

52-Week Range

$1.92 - $74.94

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Price

$3.33

Volume

1,064

Open

$3.46

Previous Close

$3.33

Daily Range

$3.32 - $3.46

52-Week Range

$1.92 - $74.94

Estimated Earnings Date

N/A

PBM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psyence Biomedical

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Marc Balkin

Headquarters

Toronto, ON M5H2K1, CA

PBM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-54%

Return on Assets

14%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$997.40K

Shares Outstanding

299.50K

Volume

1.06K

Avg. Volume

2.53M

Financials (TTM)

Gross Profit

-$4.27K

Operating Income

-$3.66M

EBITDA

$1.03M

Operating Cash Flow

-$3.73M

Capital Expenditure

-$9.88K

Free Cash Flow

-$3.74M

Cash & ST Invst.

$6.14M

Total Debt

$0.00

Psyence Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.33K

N/A

Gross Margin

0.00%

N/A

Market Cap

$997.40K

N/A

Market Cap/Employee

$83.12K

N/A

Employees

N/A

Net Income

-$753.25K

-1098.6%

EBITDA

-$749.17K

-799.9%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

$7.20M

+73325.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$174.19K

+159.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

13.83%

N/A

Return on Invested Capital

-54.49%

N/A

Free Cash Flow

-$665.00

+99.2%

Operating Cash Flow

-$662.00

+99.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-26.47%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.18-3.28%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$8.55-8.16%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.08+0.00%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.47-5.77%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00-1.36%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.45+2.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About PBM

What is the current price of Psyence Biomedical?

Psyence Biomedical is trading at $3.33 per share.

What is the 52-week range for Psyence Biomedical?

Over the past 52 weeks, Psyence Biomedical has traded between $1.92 and $74.94.

How much debt does Psyence Biomedical have?

As of the most recent reporting period, Psyence Biomedical reported total debt of $0.00.

How much cash does Psyence Biomedical have on hand?

Psyence Biomedical reported $7.20M in cash and cash equivalents in its most recent financial results.

What is Psyence Biomedical’s dividend yield?

Psyence Biomedical does not currently have a dividend yield.

Psyence Biomedical

Psyence Biomedical Financials at a Glance

PBM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Psyence Biomedical

PBM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Psyence Biomedical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PBM

What is the current price of Psyence Biomedical?

What is the 52-week range for Psyence Biomedical?

How much debt does Psyence Biomedical have?

How much cash does Psyence Biomedical have on hand?

What is Psyence Biomedical’s dividend yield?

Premium Investing Services